Combining the use of the specific inhibitors of the NLRP3 inflammasome with autophagy inducers is more effective than one single treatment in cellular or animal models of neurodegenerative diseases (Chen et al., 2019; Xu et al., 2019). The gene discussed is NLRP3; the disease is neurodegenerative disease.